BEAT: Bathi resik saben saham sajrone 12 wulan pungkasan heartbeam.com
Geopolitical tensions are hindering component supplies and limiting the expansion of HeartBeam, Inc. (BEAT) into foreign markets. The 12-month rolling earnings per share history clearly demonstrates these challenges, where -0.41 expresses the latest level of the metric. Meanwhile, the brand is strengthening thanks to an innovative AI-powered ECG device, although a narrow specialization in a single product creates certain regulatory risks for the company.
%20Bathi%20saben%20saham%20sajrone%20patang%20kuartal%20pungkasan&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_BEAT_-_HeartBeam-Inc._-_Earnings-per-share-for-the-last-four-quarters "HeartBeam Corporation - Bathi resik saben saham (EPS TTM) BEAT (periode 04.07.2022 - 14.11.2026) | 👁️GURU.Markets👁️")
Ringkesan rincian data analitis HeartBeam Inc (BEAT)
The assessment of HeartBeam, Inc. (BEAT) operational efficiency is based on its ability to generate real revenue. The eps_ttm_co metric measures trailing twelve-month net income per share, excluding market noise. The current value of -0.41 reflects the financial results of the heart monitoring systems implementation phase. Management's medtech expertise determines the trajectory of this growth. By analyzing the net income per share dynamics, an investor can discern the true inertia of the fundamental trend.
